Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 1,384 | 909 | 843 | 572 | 751 |
| Operating Income | -1,384 | -909 | -836 | -572 | -758 |
| Interest Expense | 446 | 675 | 5 | 190 | 495 |
| Other Income | -37 | -16 | -759 | 180 | -314 |
| Pre-tax Income | -1,867 | -1,601 | -1,601 | -581 | -1,567 |
| Income Tax | 0 | -109 | 1 | 1 | -117 |
| Net Income Continuous | -1,867 | -1,492 | -1,602 | -582 | -1,450 |
| Net Income | $-1,867 | $-1,492 | $-1,602 | $-582 | $-1,450 |
| EPS Basic Total Ops | -1,250.78 | -1.41 | 41.25 | -0.89 | -41.33 |
| EPS Basic Continuous Ops | -1,250.38 | -1.41 | 40.70 | -0.89 | -41.33 |
| EPS Diluted Total Ops | -1,250.78 | -1.41 | 41.25 | -0.89 | -41.33 |
| EPS Diluted Continuous Ops | -1,250.38 | -1.41 | 40.70 | -0.89 | -41.33 |
| EBITDA(a) | $-1,383 | $-909 | $-842 | $-571 | $-751 |